Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease
- PMID: 33871799
- DOI: 10.1007/s11064-021-03325-x
Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease
Abstract
Alzheimer's disease (AD) is one of the crucial causative factors for progressive dementia. Neuropathologically, AD is characterized by the extracellular accumulation of amyloid beta plaques and intracellular neurofibrillary tangles in cortical and limbic regions of the human brain. The circadian system is one of the many affected physiological processes in AD, the dysfunction of which may reflect in the irregularity of the sleep/wake cycle. The interplay of circadian and sleep disturbances inducing AD progression is bidirectional. Sleep-associated pathological alterations are frequently evident in AD. Understanding the interrelation between circadian disruption and AD may allow for earlier identification of AD pathogenesis as well as better suited approaches and potential therapies to combat dementia. In this article, we examine the existing literature related to the molecular mechanisms of the circadian clock and interacting mechanisms of circadian disruption and AD pathogenesis.
Keywords: Alzheimer’s disease; Amyloid beta; Circadian disruption; Neurofibrillary tangles; Rapid eye movement; Sleep deprivation; Slow-wave sleep.
Similar articles
-
Circadian Disruption Associated with Alzheimer's Disease.Curr Neurol Neurosci Rep. 2017 Apr;17(4):29. doi: 10.1007/s11910-017-0745-y. Curr Neurol Neurosci Rep. 2017. PMID: 28324298 Review.
-
The sleep-wake cycle and Alzheimer's disease: what do we know?Neurodegener Dis Manag. 2014;4(5):351-62. doi: 10.2217/nmt.14.33. Neurodegener Dis Manag. 2014. PMID: 25405649 Free PMC article. Review.
-
Circadian and sleep dysfunction in Alzheimer's disease.Ageing Res Rev. 2020 Jul;60:101046. doi: 10.1016/j.arr.2020.101046. Epub 2020 Apr 16. Ageing Res Rev. 2020. PMID: 32171783 Review.
-
Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.J Neurophysiol. 2019 Jul 1;122(1):1-4. doi: 10.1152/jn.00118.2019. Epub 2019 Mar 13. J Neurophysiol. 2019. PMID: 30864847 Review.
-
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis.CNS Neurol Disord Drug Targets. 2021;20(8):723-735. doi: 10.2174/1871527319666200903161249. CNS Neurol Disord Drug Targets. 2021. PMID: 32885762 Review.
Cited by
-
A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease.Int J Mol Sci. 2022 Jan 3;23(1):504. doi: 10.3390/ijms23010504. Int J Mol Sci. 2022. PMID: 35008933 Free PMC article. Review.
-
Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease.Heliyon. 2024 Apr 5;10(7):e28819. doi: 10.1016/j.heliyon.2024.e28819. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38623196 Free PMC article. Review.
-
An integrated bioinformatics analysis to identify the shared biomarkers in patients with obstructive sleep apnea syndrome and nonalcoholic fatty liver disease.Front Genet. 2024 Jul 16;15:1356105. doi: 10.3389/fgene.2024.1356105. eCollection 2024. Front Genet. 2024. PMID: 39081807 Free PMC article.
-
Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease.NPJ Biol Timing Sleep. 2025;2(1):11. doi: 10.1038/s44323-025-00025-5. Epub 2025 Mar 8. NPJ Biol Timing Sleep. 2025. PMID: 40066297 Free PMC article. Review.
-
Obstructive Sleep Apnea, Circadian Clock Disruption, and Metabolic Consequences.Metabolites. 2022 Dec 30;13(1):60. doi: 10.3390/metabo13010060. Metabolites. 2022. PMID: 36676985 Free PMC article. Review.
References
-
- Sharma P, Sharma A, Fayaz F et al (2020) Biological signatures of Alzheimer’s disease. Curr Top Med Chem 20:770–781. https://doi.org/10.2174/1568026620666200228095553 - DOI - PubMed
-
- Uddin MS, Kabir MT, Rahman MS et al (2020) Revisiting the amyloid cascade hypothesis: from anti-Aβ therapeutics to auspicious new ways for Alzheimer’s disease. Int J Mol Sci 21:5858. https://doi.org/10.3390/ijms21165858 - DOI - PMC
-
- Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111–128 - DOI
-
- Prince MJ (2015) World Alzheimer Report 2015, The global impact of dementia: an analysis of prevalence, incidence, cost and trends, 87
-
- Ashraf GM, Ebada MA, Suhail M et al (2021) Dissecting Sex-related cognition between Alzheimer’s disease and diabetes: from molecular mechanisms to potential therapeutic strategies. Oxidative Med Cell Longev 2021:4572471. https://doi.org/10.1155/2021/4572471 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical